Trafalgar International GCAN
OTC GCAN
$1.60 -0.02 (-1.23%)
At close: Sep 29, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Trafalgar International (GCAN) reported Liabilities and Shareholders Equity of $1,439 for Q1 2026, down 96.9% from $46,213 a year earlier but up 76.6% from the prior quarter.

Analysis

Trafalgar International (GCAN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Trafalgar International posted Liabilities and Shareholders Equity of $815.00, down 98.6% from FY2024.

  • Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -66.0% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $57,785 in FY2024 (-66.5%), $172,276 in FY2023 (-38.6%), $280,447 in FY2022 (-28.6%) and $392,937 in FY2021 (+118.2%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $815.00 in Q4 2025 and a high of $583,597 in Q2 2021.
  • Year over year, Liabilities and Shareholders Equity has now declined in each of the last 16 quarters, with an average decline of 74.7% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2021 (growth of 127.7%); the low point was Q4 2025 (a decline of 98.6%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $815.00 (Q4 2025), $21,355 (Q3 2025) and $26,712 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Trafalgar International 1.51 Mn 1.51 Mn - 1,439.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,439.00
Dec 31, 2025 815.00
Sep 30, 2025 21,355.00
Jun 30, 2025 26,712.00
Mar 31, 2025 46,213.00
Dec 31, 2024 57,785.00
Sep 30, 2024 63,949.00
Jun 30, 2024 83,233.00
Mar 31, 2024 133,490.00
Dec 31, 2023 172,276.00
Sep 30, 2023 206,199.00
Jun 30, 2023 248,664.00
Mar 31, 2023 260,720.00
Dec 31, 2022 280,447.00
Sep 30, 2022 300,761.00
Jun 30, 2022 324,114.00
Mar 31, 2022 381,756.00
Dec 31, 2021 392,937.00
Sep 30, 2021 509,775.00
Jun 30, 2021 583,597.00
API Access

Trafalgar International Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GCAN&period=max&api_key=YOUR_API_KEY